These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 5660065)

  • 1. Study of a sulfonyl derivative of alpha-chymotrypsin by chlorine nuclear magnetic resonance.
    Marshall AG
    Biochemistry; 1968 Jun; 7(6):2450-3. PubMed ID: 5660065
    [No Abstract]   [Full Text] [Related]  

  • 2. The inhibition of chymotrypsin A4 with a homologous series of chloromethyl ketone reagents.
    Stevenson KJ; Smillie LB
    Can J Biochem; 1970 Mar; 48(3):364-75. PubMed ID: 5438324
    [No Abstract]   [Full Text] [Related]  

  • 3. Irreversible enzyme inhibitors. CXIV. Proteolytic enzymes. IV. Additional active-site-directed irreversible inhibitors of alpha-chymotrypsin derived from phenoxyacetamides bearing a terminal sulfonyl fluoride.
    Baker BR; Hurlbut JA
    J Med Chem; 1968 Mar; 11(2):241-5. PubMed ID: 5654209
    [No Abstract]   [Full Text] [Related]  

  • 4. Irreversible enzyme inhibitors. CXLV. Proteolytic enzymes. 8. Active-site-directed irreversible inhibitors of alpha-chymotrypsin derived from alpha-(2-carboxy-4-chlorophenoxy)acetamide bearing a terminal sulfonyl fluoride.
    Baker BR; Hurlbut JA
    J Med Chem; 1969 Jan; 12(1):118-22. PubMed ID: 5763006
    [No Abstract]   [Full Text] [Related]  

  • 5. Reactions of alpha-chymotrypsin with 4-(trifluoromethyl)-alpha-bromoacetanilide.
    Ando ME; Gerig JT
    Biochemistry; 1982 May; 21(10):2299-304. PubMed ID: 7093189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural and steric specificity of alpha-chloroketones as inhibitors of alpha-chymotrypsin.
    Kumar S; Hein GE
    Biochim Biophys Acta; 1970 Jun; 206(3):404-13. PubMed ID: 5459549
    [No Abstract]   [Full Text] [Related]  

  • 7. The reactivity of His-57 in chymotrypsin to alkylation.
    Shaw E; Ruscica J
    Arch Biochem Biophys; 1971 Aug; 145(2):484-9. PubMed ID: 5132101
    [No Abstract]   [Full Text] [Related]  

  • 8. Irreversible enzyme inhibitors. 113. Proteolytic enzymes. 3. Active-site-directed irreversible inhibitors of alpha-chymotrypsin derived from phenoxyacetamides with an N-fluorosulfonylphenyl substituent.
    Baker BR; Hurlbut JA
    J Med Chem; 1968 Mar; 11(2):233-41. PubMed ID: 5654208
    [No Abstract]   [Full Text] [Related]  

  • 9. Alkylation of amide linkages and cleavage of the C chain in the enzyme-activated-substrate inhibition of alpha-chymotrypsin with N-nitrosamides.
    Donadio S; Perks HM; Tsuchiya K; White EH
    Biochemistry; 1985 May; 24(10):2447-58. PubMed ID: 4016069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ESR probing of macromolecules: spin label study of the conformational integrity and transitions in modified alpha-chymotrypsin.
    Kosman DJ; Piette LH
    Arch Biochem Biophys; 1972 Apr; 149(2):452-60. PubMed ID: 4353584
    [No Abstract]   [Full Text] [Related]  

  • 11. Hydrophobic interaction of small molecules with alpha-chymotrypsin.
    Smith RN; Hansch C
    Biochemistry; 1973 Nov; 12(24):4924-37. PubMed ID: 4761974
    [No Abstract]   [Full Text] [Related]  

  • 12. A 81Br nuclear magnetic resonance study of bromide ion binding to proteins in aqueous solution.
    Zeppezauer M; Lindman B; Forsén S; Lindqvist I
    Biochem Biophys Res Commun; 1969 Sep; 37(1):137-42. PubMed ID: 4242157
    [No Abstract]   [Full Text] [Related]  

  • 13. SULFONYL FLUORIDES AS INHIBITORS OF ESTERASES. 3. IDENTIFICATION OF SERINE AS THE SITE OF SULFONYLATION IN PHENYLMETHANESULFONYL ALPHA-CHYMOTRYPSIN.
    GOLD AM
    Biochemistry; 1965 May; 4():897-901. PubMed ID: 14337707
    [No Abstract]   [Full Text] [Related]  

  • 14. The inhibition of chymotrypsin A4 and B with chloromethyl ketone reagents.
    Stevenson KJ; Smillie LB
    Can J Biochem; 1968 Nov; 46(11):1357-70. PubMed ID: 5687069
    [No Abstract]   [Full Text] [Related]  

  • 15. Enzyme-inhibitor interactions studies via fluorine nuclear magnetic resonance. I. The interaction of alpha-chymotrypsin with DL-N-trifluoroacetylphenylalanie.
    Zeffren E; Reavill RE
    Biochem Biophys Res Commun; 1968 Jul; 32(1):73-80. PubMed ID: 5672545
    [No Abstract]   [Full Text] [Related]  

  • 16. Inactivation of alpha-chymotrypsin by a bifunctional reagent, 2-bromomethyl-3, I-benzoxazin-4-one.
    Alazard R; Béchet JJ; Dupaix A; Yon J
    Biochim Biophys Acta; 1973 Jun; 309(2):379-96. PubMed ID: 4731968
    [No Abstract]   [Full Text] [Related]  

  • 17. Evidence for hemiacetal formation between N-acyl-L-phenylalaninals and alpha-chymotrypsin by cross-saturation nuclear magnetic resonance spectroscopy.
    Chen R; Gorenstein DG; Kennedy WP; Lowe G; Nurse D; Schultz RM
    Biochemistry; 1979 Mar; 18(5):921-6. PubMed ID: 420824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Active-site specific inhibitors of elastase.
    Powers JC; Tuhy PM
    Biochemistry; 1973 Nov; 12(23):4767-74. PubMed ID: 4797992
    [No Abstract]   [Full Text] [Related]  

  • 19. Specificity in the alkylation of methionine at the active site of alpha-chymotrypsin by aromatic alpha-bromo amides.
    Lawson WB; Rao GJ
    Biochemistry; 1980 May; 19(10):2133-9. PubMed ID: 7378352
    [No Abstract]   [Full Text] [Related]  

  • 20. Specific modification of methionine-192 of -chymotrypsin by an affinity label exploiting the orienting properties of the linear acetylenic group.
    Jones JB; Hysert DW
    Biochemistry; 1972 Jul; 11(14):2726-33. PubMed ID: 5045526
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.